◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
申联生物 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
+Revenue 303.0M 301.0M 329.0M 358.0M 338.0M 254.0M 275.0M 302.0M 268.0M 241.0M 204.0M 193.0M
Revenue Growth % 0.7% -8.5% -8.1% 5.9% 33.1% -7.6% -8.9% 12.7% 11.2% 18.1% 5.7% --
Total Revenue 303.0M 301.0M 329.0M 358.0M 338.0M 254.0M 275.0M 302.0M 268.0M 241.0M 204.0M 193.0M
Cost Of Revenue 121.0M 87.9M 81.4M 87.0M 55.1M 45.0M 54.6M 60.5M 58.4M 51.3M 44.5M 42.3M
+Gross Profit 182.0M 213.1M 247.6M 271.0M 282.9M 209.0M 220.4M 241.5M 209.6M 189.7M 159.5M 150.7M
Gross Margin % 60.1% 70.8% 75.3% 75.7% 83.7% 82.3% 80.2% 80.0% 78.2% 78.7% 78.2% 78.1%
Total Operating Cost 366.0M 274.0M 260.0M 246.0M 211.0M 175.0M 180.0M 196.0M 180.0M 156.0M 138.0M 147.0M
Selling Expenses 101.0M 84.4M 73.1M 63.4M 64.0M 58.9M 63.4M 73.5M 62.9M 56.2M 45.1M 43.5M
Admin Expenses 55.2M 50.3M 55.6M 57.6M 59.4M 45.4M 41.5M 43.1M 40.4M 47.0M 49.2M 59.6M
Rd Expenses 49.4M 44.5M 39.0M 34.9M 31.9M 26.6M 21.3M 16.6M 16.7M -- -- --
Finance Expenses -734,200 -928,400 -952,900 -1.6M -2.2M -5.2M -3.4M -754,600 -1.1M -29,900 -1.2M -531,800
+Operating Income -56.5M 36.1M 75.2M 129.0M 147.0M 90.9M 101.0M 114.0M 88.4M 88.7M 72.2M 49.8M
Operating Margin % -18.7% 12.0% 22.9% 36.0% 43.5% 35.8% 36.7% 37.7% 33.0% 36.8% 35.4% 25.8%
Non Operating Income 23,300 761,300 48,900 95,100 4.0M 23,300 500,000 2.1M 2.5M 906,300 4.3M 1.3M
Non Operating Expenses 306,900 615,000 732,500 2.8M 1.4M 41,900 127,500 127,500 3,000 2.6M 3,700 6,500
Investment Income 1.8M 3.4M 3.0M 10.3M 14.6M 5.2M 2.1M 611,300 771,500 3.9M 6.4M 3.3M
Fair Value Change Income 883,300 2.4M 345,200 1.8M 753,800 -- -- -- -- -- -- --
Asset Disposal Income 35,800 500.00 136,300 101,000 -26,400 -33,900 -- 160,300 -- -- -- --
Asset Impairment Loss 28.2M -40,100 -11,700 21,600 6,000 11,300 -169,200 681,000 848,700 799,200 -529,300 630,500
Other Income 3.5M 2.6M 3.3M 4.5M 4.9M 6.6M 3.9M 7.4M -- -- -- --
Income Before Tax -56.8M 36.3M 74.6M 126.0M 150.0M 90.8M 101.0M 116.0M 91.0M 87.0M 76.5M 51.0M
Income Tax -8.0M 6.4M 13.6M 21.5M 20.6M 12.9M 13.7M 17.5M 17.5M 11.2M 15.3M 9.2M
+Net Income -48.7M 29.9M 61.0M 104.0M 129.0M 78.0M 87.6M 98.7M 73.5M 75.8M 61.1M 41.8M
Net Margin % -16.1% 9.9% 18.5% 29.1% 38.2% 30.7% 31.8% 32.7% 27.4% 31.5% 30.0% 21.7%
Net Income Attributable -44.7M 31.5M 61.1M 110.0M 130.0M 78.0M 87.6M 98.7M 73.5M 75.8M 61.1M 41.8M
Minority Interest -4.0M -1.7M -127,100 -5.7M -147,000 -- -- -- -- -- -- --
Eps Basic -0.11 0.08 0.15 0.27 0.32 0.21 0.26 0.30 0.23 0.88 -- --
Eps Diluted -0.11 0.08 0.15 0.27 0.31 0.21 0.26 0.30 0.23 0.88 -- --
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
Cash And Equivalents 146.0M 45.0M 52.7M 44.2M 115.0M 156.0M 384.0M 146.0M 165.0M 137.0M 118.0M 222.0M
Trading Financial Assets 43.8M 162.0M 305.0M 424.0M 472.0M -- -- -- -- -- -- --
Accounts Receivable 261.0M 274.0M 222.0M 151.0M 131.0M 99.7M 51.7M 79.2M 42.9M 25.9M 31.1M 72.1M
Notes Receivable -- -- 604,800 3.6M -- -- -- -- -- -- -- --
Notes And Accounts Receivable 261.0M 274.0M 223.0M 155.0M 131.0M 99.7M 51.7M 79.2M 42.9M 25.9M 31.1M 72.1M
Prepayments 1.1M 2.1M 2.7M 1.1M 678,900 906,600 3.5M 445,000 703,300 1.8M 1.2M 1.2M
Inventory 95.1M 112.0M 115.0M 103.0M 71.2M 55.7M 52.9M 51.6M 47.5M 45.2M 48.6M 46.5M
Total Current Assets 551.0M 598.0M 706.0M 733.0M 794.0M 850.0M 497.0M 284.0M 262.0M 253.0M 325.0M 348.0M
Long Term Equity Investment 1.6M 1.6M 1.6M 1.6M 1.6M -- -- -- -- -- -- --
Fixed Assets -- 658.0M 677.0M 634.0M 551.0M 193.0M 198.0M -- -- 95.1M 81.7M 85.6M
Fixed Assets Total 631.0M 658.0M 677.0M 634.0M 551.0M 193.0M 198.0M 150.0M 89.9M 95.1M 81.7M 85.6M
Construction In Progress -- 163.0M 98.9M 134.0M 92.2M 354.0M 268.0M -- -- 76.0M 69.6M 46.2M
Construction In Progress Total 178.0M 163.0M 98.9M 134.0M 92.2M 354.0M 268.0M 216.0M 214.0M 76.0M 69.6M 46.2M
Intangible Assets 103.0M 93.6M 53.1M 32.7M 33.2M 33.8M 34.4M 35.2M 36.0M 36.8M 37.7M 6.0M
Total Non Current Assets 1.0B 996.0M 900.0M 865.0M 721.0M 598.0M 516.0M 409.0M 346.0M 238.0M 204.0M 183.0M
Total Assets 1.6B 1.6B 1.6B 1.6B 1.5B 1.4B 1.0B 692.0M 608.0M 490.0M 529.0M 532.0M
Short Term Borrowings 14.0M -- -- -- -- -- -- -- -- 45.0M -- --
Accounts Payable 5.4M 5.1M 8.9M 11.3M 7.5M 2.9M 8.8M 3.9M 3.0M 3.2M 5.0M 7.8M
Advance Receipts -- -- -- -- -- 13.0M 9.7M 18.9M 11.8M 5.6M 4.7M 8.3M
Contract Liabilities 17.3M 6.6M 10.5M 8.3M 14.3M -- -- -- -- -- -- --
Total Current Liabilities 116.0M 76.5M 97.2M 114.0M 106.0M 146.0M 151.0M 119.0M 142.0M 173.0M 287.0M 204.0M
Long Term Borrowings -- -- -- -- -- 20.0M 30.0M 24.0M -- -- -- --
Total Non Current Liabilities 12.3M 10.4M 11.0M 11.9M 12.3M 20.0M 30.0M 24.0M -- -- -- --
Total Liabilities 128.0M 86.9M 108.0M 125.0M 118.0M 166.0M 181.0M 143.0M 142.0M 173.0M 287.0M 204.0M
Paid In Capital 411.0M 411.0M 411.0M 411.0M 410.0M 410.0M 360.0M 99.1M 99.1M 86.1M 86.1M 86.1M
Capital Reserve 539.0M 539.0M 546.0M 552.0M 540.0M 522.0M 171.0M 227.0M 227.0M 155.0M 2.8M --
Surplus Reserve 75.0M 75.0M 71.6M 65.9M 54.3M 41.4M 33.6M 24.8M 14.9M 7.6M -- --
Retained Earnings 405.0M 464.0M 469.0M 450.0M 392.0M 309.0M 267.0M 198.0M 124.0M 68.3M 153.0M 241.0M
Minority Equity 14.3M 18.3M -- -5.9M -147,000 -- -- -- -- -- -- --
Equity Attributable 1.4B 1.5B 1.5B 1.5B 1.4B 1.3B 832.0M 549.0M 465.0M 317.0M 242.0M 328.0M
Total Equity 1.4B 1.5B 1.5B 1.5B 1.4B 1.3B 832.0M 549.0M 465.0M 317.0M 242.0M 328.0M
Line ItemFY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017FY 2016Dec 31, 2016FY 2015Dec 31, 2015FY 2014Dec 31, 2014FY 2013Dec 31, 2013
Cash From Sales 328.0M 249.0M 264.0M 338.0M 318.0M 215.0M 302.0M 281.0M 264.0M 255.0M 250.0M 186.0M
Total Operating Cash Inflow 346.0M 261.0M 276.0M 346.0M 328.0M 249.0M 333.0M 291.0M 271.0M 263.0M 254.0M 191.0M
Cash Paid For Goods 63.1M 49.0M 71.7M 71.7M 41.3M 49.7M 44.0M 51.9M 47.4M 36.9M 38.5M 30.2M
Cash Paid To Employees 86.8M 80.4M 72.3M 69.1M 59.1M 57.1M 54.9M 50.1M 39.3M 34.1M 31.0M 29.8M
Taxes Paid 15.1M 30.9M 24.3M 28.4M 37.0M 24.3M 23.0M 30.6M 25.1M 25.8M 27.3M 26.4M
Total Operating Cash Outflow 257.0M 257.0M 266.0M 256.0M 216.0M 195.0M 211.0M 217.0M 223.0M 232.0M 148.0M 139.0M
Operating Cash Flow 89.4M 3.5M 9.1M 90.1M 112.0M 53.8M 121.0M 74.6M 48.0M 30.9M 106.0M 51.8M
Total Investing Cash Inflow 1.0B 1.5B 1.8B 3.3B 3.7B 994.0M 535.0M 91.4M 143.0M 557.0M 712.0M 296.0M
Total Investing Cash Outflow 1.0B 1.4B 1.8B 3.4B 3.8B 1.6B 613.0M 194.0M 220.0M 500.0M 852.0M 271.0M
Investing Cash Flow -3.7M 21.9M 36.0M -127.0M -90.1M -631.0M -77.4M -103.0M -76.5M 56.5M -140.0M 25.3M
Cash From Borrowings 14.0M -- -- -- -- -- 30.0M 37.5M -- 45.0M -- --
Dividends And Interest Paid 14.3M 32.8M 36.8M 40.8M 33.9M 30.3M 10.5M 15.8M 10.1M 114.0M 70.4M 13.8M
Debt Repayments -- -- -- -- 30.0M -- 27.7M 9.8M 45.0M -- -- 3.5M
Total Financing Cash Inflow 14.1M 47,200 237,200 8.6M 876,400 414.0M 235.0M 37.5M 84.5M 45.0M -- 7.4M
Total Financing Cash Outflow 33.5M 33.1M 36.9M 40.9M 64.7M 42.9M 39.2M 25.6M 55.7M 114.0M 70.4M 17.3M
Financing Cash Flow -19.4M -33.1M -36.7M -32.3M -63.9M 372.0M 196.0M 11.9M 28.8M -68.5M -70.4M -10.0M
Net Change In Cash 66.3M -7.7M 8.4M -69.4M -42.2M -206.0M 240.0M -16.0M 871,100 18.9M -104.0M 67.1M
Ending Cash Balance 111.0M 44.8M 52.5M 44.1M 114.0M 156.0M 361.0M 121.0M 137.0M 137.0M 118.0M 222.0M
Capex 84.9M 130.0M 93.1M 188.0M 164.0M 104.0M 78.8M 103.0M 116.0M 41.9M 31.6M 35.2M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...